Zymeworks
Develops antibody medicines and earns royalties from partner-run therapies.
$28.00
After-hours close−0.27 (−0.96%)
At close$28.27(−2.55%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | $2.41 | — | — |
| Aug 2026 | −$0.56 | −$0.62 | −10.3% |
| May 2026 | −$0.10 | −$0.59 | −490.0% |
| Mar 2026 | −$0.35 | −$0.55 | −57.1% |
| Nov 2025 | −$0.30 | −$0.26 | +13.3% |
The latest year is open to everyone — the 39 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Oct 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Apr 2017 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | $2.41 | — | — | $231.8M | — | — |
| Aug 6, 2026 | −$0.56 | −$0.62 | −10.3% | $4.5M | $4.6M | +1.2% |
| May 7, 2026 | −$0.10 | −$0.59 | −490.0% | $24.4M | $2.4M | −90.1% |
| Mar 2, 2026 | −$0.35 | −$0.55 | −57.1% | $19.2M | $2.5M | −86.9% |
| Nov 6, 2025 | −$0.30 | −$0.26 | +13.3% | $19.5M | $27.6M | +41.7% |
The latest year is open to everyone — the 39 quarters behind it read with an account. Sign in | ||||||
| Aug 7, 2025 | ||||||
| May 8, 2025 | ||||||
| Mar 5, 2025 | ||||||
| Oct 31, 2024 | ||||||
| Aug 1, 2024 | ||||||
| May 2, 2024 | ||||||
| Mar 6, 2024 | ||||||
| Nov 7, 2023 | ||||||
| Aug 10, 2023 | ||||||
| May 8, 2023 | ||||||
| Mar 7, 2023 | ||||||
| Nov 8, 2022 | ||||||
| Aug 4, 2022 | ||||||
| May 4, 2022 | ||||||
| Feb 24, 2022 | ||||||
| Nov 3, 2021 | ||||||
| Aug 4, 2021 | ||||||
| May 5, 2021 | ||||||
| Feb 24, 2021 | ||||||
| Nov 3, 2020 | ||||||
| Aug 5, 2020 | ||||||
| May 7, 2020 | ||||||
| Mar 2, 2020 | ||||||
| Nov 5, 2019 | ||||||
| Aug 2, 2019 | ||||||
| May 2, 2019 | ||||||
| Mar 6, 2019 | ||||||
| Nov 6, 2018 | ||||||
| Aug 1, 2018 | ||||||
| May 1, 2018 | ||||||
| Mar 14, 2018 | ||||||
| Nov 8, 2017 | ||||||
| Aug 8, 2017 | ||||||
| May 15, 2017 | ||||||
| Apr 28, 2017 | ||||||
| Sep 30, 2016 | ||||||
| Jun 30, 2016 | ||||||
| Mar 31, 2016 | ||||||
| Dec 31, 2015 | ||||||